Skip to content

Study on right heart function score system in patients with pulmonary hypertension based on multi-center cohort

Study on right heart function score system in patients with pulmonary hypertension based on multi-center cohort

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041259
Enrollment
Unknown
Registered
2020-12-23
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary hypertension

Interventions

Gold Standard:1. Diagnostic criteria for pulmonary hypertension: At rest, right heart catheter detected mPAP >= 25mmHg. 2. Diagnostic criteria for right cardiac insufficiency: cardiac MRI measurement,
was&#32
used&#32
to&#32
the&#32
and&#32
of&#32
heart.

Sponsors

The Second Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Pulmonary hypertension diagnosis and grading criteria: At rest, right heart catheter detected mPAP >= 25mmHg.According to the degree of PASP elevation, the patients were further divided into: mild pulmonary hypertension: 30mmHg = 70mmHg. (2) The following types of pulmonary hypertension patients were enrolled: Idiopathic pulmonary hypertension. Connective tissue disease correlation between pulmonary hypertension; Left to right shunt congenital heart disease, surgical/interventional postoperative pulmonary hypertension; Chronic thromboembolic pulmonary hypertension; Blood system diseases related to pulmonary hypertension. (3) Sinus rhythm; (4) Aged 18 years; (5) Good compliance, agree to participate in this study, and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with other types of pulmonary hypertension (e.g., left heart disease-associated pulmonary hypertension); (2) Right bundle branch block; (3) Patients with a history of mental illness, drug addiction or other diseases cannot sign informed consent or cooperate with the study; (4) The presence of an acute/chronic organic disease (except dyspnea) prevents the patient from completing the required items in the study; (5) Those whose condition is unstable; (6) Pregnant and breast-feeding patients.

Design outcomes

Primary

MeasureTime frame
mPAP;PAWP;RVEF;Right atrium left and right diameter(RAD 1);Right atrium length diameter (RAD 2);Right atrium area;Inner diameter of the right ventricular outflow tract;Right ventricluar left and right diameter;Right ventricular length diameter;Right ventricular wall thickness;Right ventricular area;TAPSE;S';FAC;E/A;E/e';Internal diameter of inferior vena cava;Inferior vena cava collapse rate;TR;RVGLS;PASP;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactBu Rui

The Second Affiliated Hospital of Kunming Medical University

burui0703@163.com+86 13888032143

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026